The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes
Antiadhesion molecules are effective and safe in patients with ulcerative colitis (UC). Etrolizumab, a monoclonal antibody targeting both α 4 β 7 and α E β 7 , represents a promising therapy for patients with UC, since this novel mechanism of action may be effective in blocking leukocyte recruitment...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2016-07-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/1756283X16647935 |